Bezafibrate prevents aging in <i>in vitro</i>-matured porcine oocytes.
Kim JY, Zhou D, Cui XS.
J Anim Sci Technol · research-article; journal article · DOI 10.5187/jast.2021.e64 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för bezafibrate. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
15 träffarBezafibrate activation of PPAR drives disturbances in mitochondrial redox bioenergetics and decreases the viability of cells from patients with VLCAD deficiency.
Lund M, Andersen KG, Heaton R, Hargreaves IP, Gregersen N, Olsen RKJ.
Biochim Biophys Acta Mol Basis Dis · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbadis.2021.166100PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates.
Kamata S, Oyama T, Saito K, Honda A, Yamamoto Y, Suda K, Ishikawa R, Itoh T, Watanabe Y, Shibata T, Uchida K, Suematsu M, Ishii I.
iScience · research-article; journal article · DOI 10.1016/j.isci.2020.101727Oseltamivir induces favorable response on oxidative damage in the brain of rats treated with Bezafibrate.
Calderón Guzmán D, Osnaya Brizuela N, Ortiz Herrera M, Juárez Olguín H, Veloz Corona Q, Sanchez Reyes L, Valenzuela Peraza A, Barragán Mejía G.
Int J Neurosci · journal article · DOI 10.1080/00207454.2020.1828882Efficacy of bezafibrate for preventing myopathic attacks in patients with very long-chain acyl-CoA dehydrogenase deficiency.
Shiraishi H, Yamada K, Egawa K, Ishige M, Ochi F, Watanabe A, Kawakami S, Kuzume K, Watanabe K, Sameshima K, Nakamagoe K, Tamaoka A, Asahina N, Yokoshiki S, Kobayashi K, Miyakoshi T, Oba K, Isoe T, Hayashi H, Yamaguchi S, Sato N.
Brain Dev · multicenter study; clinical study; journal article · DOI 10.1016/j.braindev.2020.07.019Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats.
Ibrahim SA, Mohamed MZ, El-Tahawy NF, Abdelrahman AM.
Can J Physiol Pharmacol · journal article · DOI 10.1139/cjpp-2020-0159Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency.
Suyama T, Shimura M, Fushimi T, Kuranobu N, Ichimoto K, Matsunaga A, Takayanagi M, Murayama K.
Mol Genet Metab Rep · journal article; case reports; case-report · DOI 10.1016/j.ymgmr.2020.100610Metabolic effects of bezafibrate in mitochondrial disease.
Steele H, Gomez-Duran A, Pyle A, Hopton S, Newman J, Stefanetti RJ, Charman SJ, Parikh JD, He L, Viscomi C, Jakovljevic DG, Hollingsworth KG, Robinson AJ, Taylor RW, Bottolo L, Horvath R, Chinnery PF.
EMBO Mol Med · research support, non-u.s. gov't; research-article; journal article; observational study · DOI 10.15252/emmm.201911589Direct observation of conformational population shifts in crystalline human hemoglobin.
Shibayama N, Ohki M, Tame JRH, Park SY.
J Biol Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1074/jbc.m117.781146Lipid-lowering fibrates extend C. elegans lifespan in a NHR-49/PPARalpha-dependent manner.
Brandstädt S, Schmeisser K, Zarse K, Ristow M.
Aging (Albany NY) · research support, non-u.s. gov't; research-article; journal article · DOI 10.18632/aging.100548Antidiabetic action of bezafibrate in a large observational database.
Flory JH, Ellenberg S, Szapary PO, Strom BL, Hennessy S.
Diabetes Care · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.2337/dc08-1809Bezafibrate, a peroxisome proliferator-activated receptors agonist, decreases body temperature and enhances electroencephalogram delta-oscillation during sleep in mice.
Chikahisa S, Tominaga K, Kawai T, Kitaoka K, Oishi K, Ishida N, Rokutan K, Séi H.
Endocrinology · research support, non-u.s. gov't; journal article · DOI 10.1210/en.2008-0285Bezafibrate improves bacterial lipopolysaccharide-induced dyslipidemia and anorexia in rats.
Harada N, Kusuyama A, Morishima M, Okada K, Takahashi A, Nakaya Y.
Metabolism · journal article · DOI 10.1016/j.metabol.2006.11.011Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null mice.
Peters JM, Aoyama T, Burns AM, Gonzalez FJ.
Biochim Biophys Acta · comparative study; research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s1388-1981(03)00065-9Crystal structure of horse carbonmonoxyhemoglobin-bezafibrate complex at 1.55-A resolution. A novel allosteric binding site in R-state hemoglobin.
Shibayama N, Miura S, Tame JR, Yonetani T, Park SY.
J Biol Chem · research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.m205461200